Michelle Eugeni
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 3
- Colorectal Cancer Treatments and Studies 2
- Cancer Treatment and Pharmacology 1
- Co-authors
- Steven K. Libutti (3 shared papers)Geoffrey Seidel (3 shared papers)Nadira Yuldasheva (2 shared papers)Yvonne Shutack (3 shared papers)Peter L. Choyke (2 shared papers)James H. Doroshow (4 shared papers)H. Richard Alexander (2 shared papers)T. Khanh (3 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Investigational New Drugs (2 papers)Journal of Vascular and Interventional Radiology (1 paper)Surgery (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesHong KongChina
In The Last Decade
Michelle Eugeni
10 papers receiving 443 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 102
- Biomaterials 85
- Oncology 157
- Neurology 75
- Epidemiology 120
Countries citing papers authored by Michelle Eugeni
This map shows the geographic impact of Michelle Eugeni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Eugeni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Eugeni more than expected).
Fields of papers citing papers by Michelle Eugeni
This network shows the impact of papers produced by Michelle Eugeni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Eugeni. The network helps show where Michelle Eugeni may publish in the future.
Co-authors
The 25 scholars most cited alongside Michelle Eugeni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 172 | |
| 2 | 2015 | 105 | |
| 3 | 2011 | 101 | |
| 4 | 2017 | 31 | |
| 5 | 2015 | 22 | |
| 6 | 2007 | 15 | |
| 7 | Phase I study of thermally sensitive liposomes containing doxorubicin (ThermoDox) given during radiofrequency ablation (RFA) in patients with unresectable hepatic malignancies | 2007 | 4 |
| 8 | 2007 | 3 | |
| 9 | 2007 | 2 | |
| 10 | 2013 | 1 |
About Michelle Eugeni
Michelle Eugeni is a scholar working on Molecular Biology, Oncology, Epidemiology, Biomaterials and Biotechnology, having authored 10 papers that have together received 456 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer Research and Treatments (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Cancer Treatment and Pharmacology (1 paper) and Nanoplatforms for cancer theranostics (1 paper). The work is most often cited by research in Cancer Research (102 citations), Biomaterials (85 citations), Oncology (157 citations), Neurology (75 citations) and Epidemiology (120 citations). Michelle Eugeni has collaborated with scholars based in United States, Hong Kong and China. Frequent co-authors include Steven K. Libutti, Geoffrey Seidel, Nadira Yuldasheva, Yvonne Shutack, Peter L. Choyke, James H. Doroshow, H. Richard Alexander, T. Khanh, James F. Pingpank and Shivaani Kummar. Their work appears in journals such as Journal of Clinical Oncology, Investigational New Drugs, Journal of Vascular and Interventional Radiology, Surgery and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.